Skin Autofluorescence Is Associated With 5-Year Mortality and Cardiovascular Events in Patients With Peripheral Artery Disease

High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease

(2013) W. Schuyler Jones et al.   AMERICAN HEART JOURNAL

Oxidation-Specific Biomarkers and Risk of Peripheral Artery Disease

(2013) Monica L. Bertoia et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Skin Autofluorescence as a Measure of Advanced Glycation End Products Deposition Is Elevated in Peripheral Artery Disease

(2012) Lisanne C. de Vos et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Advanced glycation end product associated skin autofluorescence: A mirror of vascular function?

(2012) Britt Hofmann et al.   EXPERIMENTAL GERONTOLOGY

Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease

(2011) Marjon J. Noordzij et al.   INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING

Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease

(2010) Andries J Smit et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Carotid artery intima media thickness associates with skin autofluoresence in non-diabetic subjects without clinically manifest cardiovascular disease

(2010) Helen L. Lutgers et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Serum Pentosidine, An Advanced Glycation End Product, Indicates Poor Outcomes After Acute Ischemic Stroke

(2010) Toshiki Ikeda et al.   Journal of Stroke & Cerebrovascular Diseases

Skin color independent assessment of aging using skin autofluorescence

(2010) M. Koetsier et al.   OPTICS EXPRESS

Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events

(2010) D. J. Mulder et al.   Netherlands Heart Journal

Elevation of the glycoxidation product Nε-(carboxymethyl)lysine in patients presenting with acute myocardial infarction

(2009) Stefan Kralev et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus

(2009) H. L. Lutgers et al.   DIABETOLOGIA

Advanced Glycation End Products in Patients with Cerebral Infarction

(2009) Yuko Ohnuki et al.   INTERNAL MEDICINE

The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation

(2008) A. C. Calkin et al.   DIABETOLOGIA